The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. iData’s cardiovascular device market reports also include cardiac surgery, cardiac rhythm management, and other cardiovascular devices and procedures. Check out our different cardiovascular device market reports below.
The Australian dialysis catheter market is composed of short-term (acute) hemodialysis, and long-term (chronic) hemodialysis. The largest segment in the total dialysis catheter market in 2016 was represented by short-term hemodialysis catheters. The second largest market is the long-term hemodialysis catheters. The value of the total dialysis catheter market is expected to grow slightly over the forecast period.
The Australian market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. The Australian market for implantable ports has been contracting due to a shift away from conventional and towards power-injectable implantable ports. This is further amplified as a result of strong declines in ASPs for power-injectable implantable ports as competitors are expecting strong growth for this segment.
The Australian market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Power-injectable PICCs have become the standard of care in Australia and in the United States, whereas Japan still prefers conventional PICCs. In 2016, power-injectable PICCs represented less than 70% of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.
The Australian market for peripheral intravenous catheters (PIVCs) is split up into two segments: conventional PIVC and safety PIVC. PIVCs are inserted in veins and arteries. An arterial access site is utilized in patients that require blood pressure monitoring. Firmer catheters are preferred for arterial access. A venous access site is utilized for infusing fluids, providing antibiotic treatment and other standard procedures.
The total Australian market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the safety port needles. This segment is experiencing higher unit sales growth than the conventional port needle segment; however, this is slightly balanced by more moderate price declines.